Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women
about
Unstable mutations in the FMR1 gene and the phenotypesThe FMR1 gene, infertility, and reproductive decision-making: a reviewStudy of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 GeneA Variance-Component Framework for Pedigree Analysis of Continuous and Categorical Outcomes.Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers.Premature ovarian failure in the fragile X syndrome.Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriersOvarian abnormalities in a mouse model of fragile X primary ovarian insufficiency.Reproductive and menstrual history of females with fragile X expansionsEndocrine Dysfunction in Female FMR1 Premutation Carriers: Characteristics and Association with Ill Health.Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives.Fragile X-Associated Diminished Ovarian Reserve and Primary Ovarian Insufficiency from Molecular Mechanisms to Clinical Manifestations.Frequency of FMR1 premutation carriers and rate of expansion to full mutation in a retrospective diagnostic FMR1 Korean sample.Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers.Association of FMR1 repeat size with ovarian dysfunction.FMR6 may play a role in the pathogenesis of fragile X-associated premature ovarian insufficiency.Examination of reproductive aging milestones among women who carry the FMR1 premutation.
P2860
Q26996649-852D6D4B-C91E-429F-A268-166343242223Q27026782-FF91CD3B-0645-4D85-8426-ECBB33C9014AQ28077015-231FD01D-A6C4-42BF-B46C-52B00CC46A88Q33812475-A7669412-4CA3-4C57-B969-5BACF870EB63Q33897004-3D48FBC1-EEFB-4044-BE85-CE73F88EF73AQ34083509-076D54FC-C408-4E79-B60E-2AD0F4DAB1D3Q34306135-D6C7CF80-2FB9-40DE-866B-20B4730FE6BBQ35108269-4BCEDA1B-F026-42C4-9FAE-352C25E7C738Q36085633-40F45C08-8B0D-441C-B515-BD195110439EQ37050992-25D72DE6-EA6A-4C8B-917A-0C05828620C5Q37449715-963B859E-87E3-4A37-B676-904D62F82E97Q40721679-CE74DA25-1948-4B62-BEF1-1DB70D48984DQ41684295-3C175B6E-59B9-4D5E-8AF7-29156AAD2A00Q43628490-379DF30C-1B96-4E57-9A5D-B143C872D880Q46017473-3995EF47-13E3-426C-AA17-D6B3D33D143EQ47397588-D51047F5-1DB7-4160-93D8-3C2BFF950729Q48562397-721E482B-7946-4BBA-88B9-6C714588E460Q48788754-42D928D2-8EA4-4464-A36C-BCC5AAEEF6EF
P2860
Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum concentrations of follic ...... ure in FRAXA premutation women
@en
Serum concentrations of follic ...... re in FRAXA premutation women.
@nl
type
label
Serum concentrations of follic ...... ure in FRAXA premutation women
@en
Serum concentrations of follic ...... re in FRAXA premutation women.
@nl
prefLabel
Serum concentrations of follic ...... ure in FRAXA premutation women
@en
Serum concentrations of follic ...... re in FRAXA premutation women.
@nl
P2093
P2860
P356
P1433
P1476
Serum concentrations of follic ...... ure in FRAXA premutation women
@en
P2093
P2860
P304
P356
10.1093/HUMREP/14.5.1217
P407
P577
1999-05-01T00:00:00Z